SCIENCE IN THE NEWS DAILY
Vaccine Doubles Brain Cancer Survival Time
from the Guardian (UK)
A vaccine that more than doubles the survival time of patients with the most common and aggressive form of brain cancer has been developed by scientists.
Early results from clinical trials suggest patients who received the vaccine lived for nearly three years after being diagnosed with glioblastoma multiforme.
Patients given traditional anti-cancer treatment, including a combination of surgery, chemotherapy and radiotherapy, typically survived for a little more than a year following diagnosis. John Sampson, a neurosurgeon at Duke University's brain tumour centre in North Carolina, who led the trial, said: "We're more than doubling the survival time in this group, and we have some patients who are four, five or six years out from diagnosis, which is virtually unheard of in these people."
Read more ...
Connect With Us:
PODCAST & VIDEO: Engineering Around Extreme Events
Extreme events, such as super floods and hurricanes, are becoming more common, so civil engineers are trying to adapt civil infrastructure such as bridges to these unpredictable and sometimes devastating meteorological events. Engineer Ana Barros discusses how engineering can prepare us for extreme weather events, but also how changing climate and population conditions can affect the ability of infrastructure to hold up over time.
To view all multimedia content, click "Latest Multimedia."
Receive notification when new content is posted from the entire website, or choose from the customized feeds available.